Answers are grounded in this paper and cite their sources.
Glaucoma remains the leading cause of global irreversible blindness, imposing a disproportionately severe public health and economic challenge across South Asia.1,2 Across Bangladesh, India, Pakistan, Nepal, and Sri Lanka, the overall pooled population prevalence of glaucoma among adults aged 40 years and older is estimated at 2.1% (95% CI: 1.7–2.6%), with Primary Open-Angle Glaucoma (POAG) being the predominant variant (1.6%), followed by Primary Angle-Closure Glaucoma (PACG, 0.7%) and secondary glaucomas (0.3%).1,3 The disease is characterized by an insidious onset, high asymptomatic latency, and profound diagnostic delays, resulting in over 75% to 90% of cases remaining undiagnosed until advanced optic nerve head damage has occurred.1,4,7 This expanded review synthesizes current epidemiological metrics, risk profiles, structural health system bottlenecks, and clinical patterns across five South Asian nations. Additionally, it addresses review limitations, data availability, ethical considerations, and funding disclosures. J. Natl.Inst. Ophthalmol.2025;8(2): 69-72
No takes yet. Share an insight, caveat, or question.
Roy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: